|
|
|
 |
|
Agam, Galila
J. Dreyfus Professor of Biochemistry in Psychiatry, Psychiatry Research Unit and Department of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, ISRAEL
|
Dr AGAM is a member of the Scientific Advisory Committee of the National Institute for Psychobiology in Israel. Is B.Sc., Chemistry, Biochemistry, Hebrew University, Jerusalem, M.Sc., Medical Sciences/Biochemistry - with distinction; Hebrew University, Jerusalem, Israel and Ph.D., Summa Cum Laude, Ben Gurion University of the Negev, Beersheva, Israel.
She has received grants from the Israel Institute for Psychobiology, the Harry Stern Psychobiology Foundation, the Stanley Foundation, the Israel Ministry of Health, the US National Alliance for Research on Schizophrenia and Depression (NARSAD), the Bi-National USA-Israel Science Foundation, the Dreyfus Health Foundation, the Chief Scientist of the Israel Ministry of Industry, Commerce and Labor. She has co-authored 115 Papers and 37 book chapters, edited one book and two journal special issues
|
|
Aitchison, Katherine
Senior Lecturer in Adult Psychiatry, MRC SGDP Centre, Institute of Psychiatry at King's College London and Honorary Consultant Psychiatrist, South London & Maudsley NHS Foundation Trust, UNITED KINGDOM
|
Dr Aitchison received a First Class BA (Hons) in Physiological Sciences from Oxford University in 1987, with a top University Prize, her MRCPsych in 1996, and a PhD in the role of genetic variation in cytochrome P450 enzymes in antidepressant and antipsychotic treatment response from UCL in 2003 (funded by a Wellcome Trust Fellowship). This included work at NIH and the University of Colorado (USA) on a Lilly Travelling Fellowship awarded by the Royal College of Psychiatrists. She was appointed as a Senior Lecturer and Honorary Consultant Psychiatrist in 2001, and joined the MRC SGDP Centre as an Executive Member in 2003. She has been the Deputy Coordinator of a multicentre integrated programme of research funded by the European Commission under the Framework 6 Programme (GENDEP, http://gendep.iop.kcl.ac.uk/results.php), and has run and contributed to other translational medicine projects. Her awards include a Junior Investigator Award at the World Congress of Psychiatric Genetics (1995), a Young Investigator Award for the International Congress in Schizophrenia Research (ICOSR 1997), a Young Scientist Award at the 10th Biennial Winter Workshop on Schizophrenia (2000), and a Scholarship to present at the 2008 Meeting on Pharmacogenomics, held at Cold Spring Harbor Laboratory, NY. She has served on international Committees including the Annual Pharmacogenetics in Psychiatry Meeting Faculty, the Translating Advances in Biological Psychiatry into Therapeutics Conference Organising Committee, on Editorial Boards including the Journal of Psychopharmacology, and co-leads the Psychopharmacology Special Interest Group of the Royal College of Psychiatrists.
|
|
Akiskal, Hagop
Professor of Psychiatry and Director of the International Mood Center at the University of California at San Diego, USA
|
Dr. Akiskal obtained his medical degree (Alpha Omega Alpha) from the American University of Beirut in 1969. Thereafter he settled in the United States and obtained his psychiatric training at the Universities of Tennessee, Memphis and Wisconsin, Madison. He was appointed Professor of Psychiatry and Pharmacology at the University of Tennessee (1972-1990), and subsequently recruited as the Senior Science Advisor to the Director of the National Institute of Mental Health (1990-1994). He is presently Professor of Psychiatry and Director of the International Mood Center at the University of California at San Diego. He holds an honorary doctorate degree from the University of Lisbon. Since 1996, he is the Editor-in-Chief of the Journal of Affective Disorders.
Professor Akiskal rose to prominence with his integrative theory of depression (Science, 1973). Subsequently he established chronic depressions as treatable mood disorders. His research on cyclothymia paved the way for understanding the childhood antecedents of bipolarity, and helped in the worldwide renaissance of the temperament field. His focus on subthreshold mood disorders enlarged the boundaries of bipolar disorders. He has received the Gold Medal for Pioneer Research (Society of Biological Psychiatry), the German Anna Monika Prize for Depression, the NARSAD Prize for Affective Disorders, the Jean Delay Prize for international collaborative research (World Psychiatric Association), as well as the French Jules Baillarger and the Italian Aretaeus Prizes for his research on the bipolar spectrum.
Professor Akiskal has pioneered in the study of outpatient mood disorders. At the University of Tennessee, he established mood clinics which have had worldwide appeal because of his philosophy of conducting clinical training and research while delivering high quality care. His clinical expertise ranges from dysthymia to bipolar spectrum disorders, as well as comorbidity, resistant depression, interface of personality with mood disorders, mixed states, anxious bipolarity, and PTSD. In 2003, he received the Ellis Island Medal of Honor "for exceptional national humanitarian service." He consults and lectures internationally.
|
|
Arboleda-Florez, Julio
Professor Emeritus and immediate past Head, Department of Psychiatry, Queen's University, CANADA
|
Dr Arboleda-Flórez, MD, FRCPC, DABFP, PhD, DLFAPA, FCPA, FRSM, Forensic Psychiatrist, Epidemiologist is Professor Emeritus and immediate past Head, Department of Psychiatry, Queen's University, Canada; immediate past Chief-of Psychiatry Queen's Affiliated Hospitals. He is Honorary Professor, Universidad de Chile; Adjunct and Visiting Professor at several international universities; researcher (mental health systems, stigma, psychiatric epidemiology, mental illness and violence), author, international lecturer; versed in several European languages. Professor Arboleda-Flórez is Distinguished Life Fellow American Psychiatric Association; Inaugural Fellow of the Canadian Psychiatric Association and Fellow of the American College of Forensic Psychiatry and American Board of Forensic Examiners; Fellow Royal Society of Medicine; Honorary Member World Psychiatric Association and Asociación Ecuatoriana de Psiquiatría; Member Emeritus, Forensic Department, Associaõ Brasileira de Psiquiatría; past-President International Academy of Law and Mental Health; immediate past President Canadian Academy of Psychiatric Epidemiology; immediate past Chairman Forensic Section World Psychiatric Association. He is also Honorary Life President of the Forensic Section, World Psychiatric Association and President World Association for Social Psychiatry.
|
|
Awad, George
Professor emeritus in the Department of Psychiatry, and Faculty of the School of Graduate Studies in the Institute of Medical Science, University of Toronto, CANADA
|
Dr. Awad is a professor emeritus in the Department of Psychiatry, and on the Faculty of the School of Graduate Studies in the Institute of Medical Science, University of Toronto. He also serves as the Psychiatrist in Chief of the Department of Psychiatry and Mental Health at Humber River Regional Hospital in Toronto. Dr. Awad continues to serve as a national and international reviewer and consultant for academic and service programs. He also serves in several national and international organizations, including recently being elected as the first Founding President of the newly developed International Society for CNS Clinical Trails and Methodology (ISCTM). He also served as the eleventh president of the Canadian College of Neuropsychopharmacology. He chaired and served on a number of NIH, NIMH, CINP committees. He continues to serve as a member of the International Advisory Board to the German federal government, which oversees the network of Schizophrenia Centres of Excellence in Germany. Dr. Awad made significant contributions to the Canadian Psychiatric Research Foundation, having chaired its Professional Advisory Board for a number of years and was instrumental with support from the Tanenbaum family to establish the Tanenbaum Distinguished Scientist Award in Schizophrenia. Dr. Awad was honoured to receive such an award in 1998. In 2000, he was also awarded the Canadian College of Neuropsychopharmacology medal for meritorious contributions in psychopharmacology research, teaching and services. Dr. Awad is recognized for his national and international contributions that has led to significant research development in such areas as quality of life, subjective tolerability to medications and patient reported outcomes, and outcomes research in general.
|
|
Bobes, Julio
Professor and Chair of Psychiatry at the University of Oviedo (Asturias) and Clinical Director of Psychiatric Services for the Oviedo Area SPAIN
|
Dr Bobes is Principal Investigator of the Oviedo node of the National Network of Mental Health Biomedical Research centres (Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)), funded by Instituto de Salud Carlos III of the Spanish Ministry of Science and Innovation. He has a longstanding track record of attaining research funding at national and European level. His primary research interests are the evaluation, management, treatment and assessment of the impact of various psychiatric disorders, including addiction, psychosis, affective, anxiety and psychophysiology disorders. He also pursues a research interest relating to the prevention of suicidal behaviour. He has lectured extensively at national and international conferences. He has published more than 100 peer-reviewed papers and has contributed to many academic textbooks as author and editor. He is a member of many academic and professional societies and is currently President of the Spanish Society of Biological Psychiatry and a member of the Board of the European Psychiatric Association.
|
|
Câmara-Pestana, Luis
Psychiatrist, clinical pharmacologist President of the Portuguese Association of Biological Psychiatry and consultant of the Portuguese Authority of Drugs and Pharmacy, PORTUGAL.
|
Dr Câmara Pestana's main area of scientific research is clinical psychiatry and psychiatric disorders in association with Epilepsy. He has been involved in the organisation of various national and international meetings namely the 1997 European College of Neuropsychopharmacology (ECNP) regional meeting and the 17th European Congress of Psychiatry. In the past he had participated in several psychopharmacological clinical trials. He has published 35 papers and over 160 scientific presentations in national and international meetings.
|
|
Massimo Cocchi
Professor of Nutrition Biochemistry, Faculty of Human and Technological Sciences, LUdeS University, Lugano, SWITZERLAND
|
Professor Massimo Cocchi was born in Bologna on 8th, October 1945. He attended the University of Bologna where he graduated in Medicine in 1971. He studied Nutrition and Biochemistry at an advanced level, throughout the first five years of the Medical Degree Course at the Institute of Biochemistry of the University of Bologna.
The major scientific research has always been connected with aspects of lipid metabolism in both, experimental animals and man.
Summary of original scientific work in: Biochemistry of Nutrition and lipid metabolism
1) Ethanol and lipid 2) Dietary lipids, tissue lipids and unusual fatty acids 3) Studies about Essential Fatty Acids (EFA) 4) Fatty Acids of the n-6 and n-3 series 5) Cellular nutrition 6) Lipid metabolism during development and growth 7) Platelet fatty acids in Major Depression and Ischemic Cardiovascular Disease.
In 1995 he has been appointed as Professor of Nutrition Biochemistry (Scottish Agricultural College). In 2005 he has been appointed as Contract Professor of Food and Human Nutrition at the Faculty of Veterinary Medicine of the University of Bologna. In 2005 he started to study the platelet fatty acids in groups of patients (Depressive and Ischemic) realizing a combination between Biochemistry and Artificial Neural Network which has allowed to characterize the depressive and the ischemic population versus the apparently normal people.
In 2009 he has been appointed as Full Professor of Nutrition Biochemistry at the Faculty of Human and Technological Sciences, LUdeS University, Lugano, Switzerland
|
|
Cookson, John
Consultant and Honorary Senior Lecturer in Psychiatry at The Royal London Hospital in London, England, UNITED KINGDOM.
|
John Cookson obtained a doctorate in pharmacology at Oxford, and studied clinical medicine at University College Hospital in London. His higher training in Medicine was in London and in Psychiatry was at St. Bartholomew's and the Maudsley Hospitals.
He is responsible for a catchment area service comprising a community mental health team and a general psychiatric ward, with access to a Home Treatment Team, an Early Intervention Service and an Assertive Outreach Team. He was consultant for a Psychiatric Intensive Care Unit from 1988-2007, and for a Specialist Addictions Unit from 1981-1996.
Dr. Cookson's research interests are in psychopharmacology and the use of drugs in psychiatry, particularly in relation to the treatment of bipolar disorder.
He has participated in the development of new drugs for bipolar disorder, schizophrenia, depression, social phobia, and panic disorder. He serves on the editorial boards of The British Journal of Psychiatry, International Clinical Psychopharmacology, and Advances in Psychiatric Treatment. He coauthored the fourth and fifth editions (2002) of Use of Drugs in Psychiatry: The Evidence from Psychopharmacology, published by the Royal College of Psychiatrists. He participated in the British Association for Psychopharmacology Guidelines for Bipolar Disorder.
|
|
De Hert, Mark
Clinical psychiatrist and psychotherapist, University Psychiatric Centre Katholieke Universiteit Leuven, campus Kortenberg, BELGIUM
|
His main clinical focus is schizophrenia and other psychotic disorders. He is head of a residential rehabilitation ward and also runs a day-hospital and an outpatient clinic for people with psychotic disorders. In Brussels he is involved in sheltered housing projects and a pilot project of Assertive Community Treatment.
He studied medicine at the University of Antwerpen, where he also qualified as a psychiatrist. He had a formal training in both psychoanalysis and systemic family therapy. He has a PhD in biomedical sciences from the Katholieke Universiteit Leuven (Suicide in young patients with schizophrenia). He is involved in training of paramedical professionals, psychiatric nurses, medical students and trainees in psychiatry. He is a lecturer and Professor at the Catholic University Louvain.
His main research domains have been epidemiology, treatment and outcome of psychotic disorders. Current research projects involve evaluation of rehabilitation interventions, long-term outcome studies, somatic co-morbidities in people with severe mental illness, pharmacogenetics and the evaluation of metabolic and other side-effects of antipsychotic medication.
|
|
Douzenis, Athanasios
Assistant Professor in Forensic Psychiatry, 2nd Psychiatry Department at Attikon University General Hospital, Athens University Medical School, GREECE
|
Dr Douzenis was born in 1959 in Athens Greece. Currently is Assistant Professor in Forensic Psychiatry Athens University Medical School and works in the 2nd Psychiatry Department at Attikon University General Hospital in Athens. He graduated from Athens University Medical school in 1985 and received his Master of Medical Sciences at Sheffield University, UK in 1988 and his PhD in 1995 at the University of Athens). He had is post-graduate training in Psychiatry and Forensic Psychiatry at the Charing Cross and Westminster Medical School in London UK. His professional experience includes Locum Consultant Croydon MH and Riverside MHA in London (1995), Organization Against Narcotics (OKANA) being director of the substitution Unit in Athens (1995-2000).
He served as lecturer in Forensic Psychiatry (2000-2005) and currently as assistant profesor in Forensic Psychiatry Athens University Medical School.
His scientific work includes 20 publications included in the SCI and 21 chapters in books (3with international publishers).
He is member of the Royal College of Psychiatrists, European Violence in Psychiatry Research Group and the Greek Psychiatric Association and currently chairs the Section of Forensic Psychiatry of theGreek Psychiatric Association
|
|
Erfurth, Andreas
Head of Clin Psychopharmacology and the Bipolar Spectrum Disorders Program, Division of General Psychiatry, Medical University of Vienna, AUSTRIA
|
Priv.-Doz. Dr. med. Andreas Erfurth was born in Hamburg, Germany in 1961 and received his education at the Conservatorio di Musica di Santa Cecilia, Rome, Italy, the Richard-Strauss-Konservatorium, Munich, Germany and the Medical School, University of Munich, Germany.
He was resident in psychiatry at the University of Munich, Germany and was research fellow at the Laboratory of Neuroendocrine Regulation, Department of Brain and Cognitive Sciences, M.I.T., Cambridge, Massachusetts, U.S.A. Hospital appointments include the University of Munich and the University of Muenster, Germany, where he wrote his habilitation thesis.
At present Dr. Erfurth is secretary of the European Bipolar Forum (www.EuBF.org) and of the Verein für Psychiatrie und Neurologie, Vienna. He was co-founder and secretary of the German Society for Bipolar Disorders.
His is particularly interested in the diagnosis, neurobiology and therapy of affective disorders.
|
|
Fagiolini, Andrea
Chairman and residency Training Director, Division of Psychiatry, University of Siena School of Medicine Siena, ITALY
|
University of Pittsburgh Medical School, in the Department of Psychiatry, where he has served as Medical Director of the Bipolar Disorder Center and of the Depression and Manic Depression Prevention Program. More recently, he has joined the faculty at the University of Siena School of Medicine, Siena Italy. Professor Fagiolini's has published several books and papers in peer reviewed international journals. His research interests and publications have primarily focused on Bipolar and Major Depressive disorders. The topics of his research include the pharmacological treatment of mood disorders, suicidality, functional impairment and quality of life in patients with bipolar disease, and the relationship between bipolar disorder and medical conditions such as obesity and other metabolic disturbances.
|
|
Figueira, Maria Luisa
Professor of Psychiatry, Faculty of Medicine, University of Lisbon, and Head of the Psychiatric Department Hospital Santa Maria, University of Lisbon, PORTUGAL.
|
Dr Figueira's area of scientific research is clinical and experimental psychopathology (bipolar disorders) and clinical psychopharmacology. Professor Figueira has been involved in the organisation of various meetings including the 1997 European College of Neuropsychopharmacology (ECNP) regional meeting, the 17th European Congress of Psychiatry that took place in Lisbon 2008 and International Symposia on Bipolar Disorders (1994-2009) since 1997 in cooperation with Hagop Akiskal - Honorary President (Univ. San Diego). Between 1996 and 2005 she was involved as a principal investigator in many pharmacological clinical trials including six phase III studies and four phase II studies. Professor Figueira has been a fellow of the Collegium Internationale Neuro-psychopharmacologicum (CINP) since 1978, the European Association of Psychiatry (EAP) since 2002 and the International Society of Affective Disorders (ISAD) since 2003. She has published over 100 manuscripts in national and international peer-reviewed journals.
|
|
Fuller, Bret
Program Coordinator, NW Hepatitis C Resource Center and Staff Psychologist, Portland VA Medical Center, Portland, Oregon, USA
|
Bret Fuller is a Clinical Psychologist in VA and a clinical member of the Department of Public Health and Preventive Medicine at Oregon Health and Science University. He earned his Ph.D. from the University of Missouri-Columbia in Counseling Psychology and completed a three year post-doctoral fellowship in addiction studies at the University of Michigan. Dr. Fuller spent six years at Oregon Health and Science University where he published in the areas of substance abuse treatment, methadone policy and smoking cessation. Currently, he is the program coordinator for the VA Northwest Hepatitis C Resource Center and a psychologist in the Portland VA Medical Center, Mental Health Division.
|
|
Fountoulakis, Konstantinos
Assistant Professor of Psychiatry, 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, GREECE
|
Dr. Fountoulakis received his medical degree (1989), performed his residency in psychiatry (1998), and earned his PhD in psychiatry (1999) at the Aristotle University of Thessaloniki. He received a 3-year fellowship in psychosomatic medicine and a 1-year postdoctoral fellowship for research from the State Scholarships Foundation of Greece. Until 2003 he served as a medical officer in the Greek Armed forces retired with the rank of major. In 2005, Dr. Fountoulakis was a Research Fellow in the Department of Psychiatry, Division of Neuropsychiatry, at the University of Geneva. His teaching areas and of clinical and research interest are: general psychiatry, biological psychiatry, psychopharmacology, and personality disorders. He is an active member of a number of national and international professional organizations, including the EPA, APA, WPA, CINP, ECNP, ISAD, ISBD, EBF, the Cochrane Collaboration and others and was most recently a member of the CINP Advisory Board to the Task Force on the Usefulness of Antidepressants and the Mental Health Economics Task Force of the IPA. He chairs the ISNP and since 2006, he served as Secretary, and since 2008 as co-chair of the Private Practice Section, of the WPA. He is Chair, Neuropsychological and Psychometric Instruments Section, of the Greek Psychiatric Association.
Dr. Fountoulakis is Editor in Chief of Annals of General Psychiatry and is Guest Editor of Current Opinion in Psychiatry. He has coauthored more than 250 papers; more than 90 of them are published in international journals such as IJNP, JAD, Schizophrenia Research, Psychiatry Research, Bipolar Disorders, and the British Journal of Psychiatry. He has received a number of national and international research awards.
In 2009 was appointed member of the Greek Ministry of Health Committee for the Administrative, Economic and Scientific Supervision of the Mental Health Units of the deinstitutionalization project.
|
|
Gaebel, Wolfgang
Professor of Psychiatry, Director of the Department of Psychiatry and Psychotherapy at the Heinrich-Heine University, Duesseldorf, and Head of the LVR Klinikum Duesseldorf, GERMANY
|
Wolfgang Gaebel, born 1947 in Braunschweig, Germany, and was qualified in medicine at the Free University of Berlin (FUB), Germany, then took up postgraduate training in Neurology at Rudolf-Virchow-Hospital in Berlin and Psychiatry at the Department of Psychiatry at the FUB. After specializing in Psychiatry, Psychotherapy and Neurology he continued working as Research Assistant, then Senior Psychiatrist at the Department of Psychiatry at the FUB, at the same time becoming appointed as State Physician for Mentally Handicapped Persons at the Senator for Health and Social Affairs in Berlin. In 1989 he obtained a grant of the German Research Foundation for a Research Stay at the Department of Psychology at the University of Lethbridge, Alberta, Canada. In 1992 he took up his present position.
During his career, Professor Gaebel has held positions as President of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN, 1995/6), and President of the German Society of Biological Psychiatry (DGBP, 1999/02). He was Chair of the Organizing Committee of the 11th World Congress of Psychiatry, Hamburg, 1999. He is Vice President of the Association of the Scientific Medical Societies in Germany (AWMF), member of the Deutsche Akademie der Naturforscher LEOPOLDINA, member of several National Ethical Committees, chairman of the Section on Schizophrenia as well as co-chairman of the Section on Quality Assurance and honorary member of the World Psychiatric Association (WPA), and chairman of the Taskforce on Nosology and Psychopathology of the World Federation of Societies of Biological Psychiatry (WFSBP).
Prof. Gaebel was again elected as President of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN) for the period 2007 - 2008. He was elected as a Board Member of the European Psychiatric Association (EPA) with effect of 01 January 2009 and he was elected as co-chairman of the EPA Section on Schizophrenia.
His research focus includes clinical, pharmacological, and neurophysiological aspects of schizophrenia, experimental psychopathology, treatment guidelines and quality management, and research on stigma and discrimination. His current interest is on the development of diagnosis and classification towards ICD-11 and DSM-V; he is member of the Global Scientific Partnership Network appointed by WHO.
Professor Gaebel has published about 500 scientific articles and is editor or author of about 30 books/supplements on a range of topics.
|
|
Galderisi, Silvana
Professor of Psychiatry and Director of the training school in Psychiatry at the University of Naples SUN, ITALY
|
Silvana Galderisi, is member of the Board of the European Psychiatric Association and Chairperson of the Section on Schizophrenia of the same Association. She is founding member of the European Group for Research in Schizophrenia and Board member of that organisation. Additionally, she is Chairperson of the Psychophysiology Section in Psychiatry of the World Psychiatric Association and President Elect and General Secretary of the EEG & Clinical Neuroscience Society. Her scientific work has been published in high impact international journals including Lancet, American Journal of Psychiatry, British Journal of Psychiatry, Biological Psychiatry, Archives of Clinical Neuropsychology, Neuroimage, Human Brain Mapping, Neuroscience, Schizophrenia Bulletin and Schizophrenia Research.
|
|
Ganança, Licínia
Psychiatry resident, Psychiatric Department, Hospital Santa Maria, University of Lisbon and consultant of the Portuguese Authority of Drugs and Pharmacy, PORTUGAL
|
Licínia Ganança is a 3rd year psychiatry resident at the Psychiatric Department at the Hospital Santa Maria, University of Lisbon and a consultant of the Portuguese Authority of Drugs and Pharmacy. Her main areas of research are psychogeriatrics and psychiatric disorders in association with Epilepsy. Has participated in around 10 poster presentations in national and international meetings. Licínia Ganança a member of the Portuguese Association of Biological Psychiatry.
|
|
Gelenberg Alan
Professor Emeritus, University of Arizona's Department of Psychiatry, and Clinical Professor at the University of Wisconsin-Madison, USA.
|
For 18 years, he was Professor and Head of the University of Arizona's Department of Psychiatry, where he remains Professor Emeritus, and is currently Clinical Professor at the University of Wisconsin-Madison. Has been on the faculties of Harvard, Massachusetts General Hospital, and M.I.T. Since 1987 Dr. Gelenberg has been Editor-in-Chief of the Journal of Clinical Psychiatry, Dr. Gelenberg has been lead author of manuscripts in the Lancet, New England Journal of Medicine, and JAMA and has authored over 260 scientific articles, editorials, and book chapters. He chairs the APA workgroup on Treatment Guidelines for Major Depressive Disorder, was on a joint APA/AMA taskforce on similar guidelines for primary care, has sat on NMIH committees, is a Distinguished Life Fellow of the APA, former chair of its Committee on Research on Psychiatric Treatments, past President of the West Coast College of Biological Psychiatry, fellow of the American College of Neuropsychopharmacology, and member of the American College of Psychiatrists. He now chairs the Data and Safety Monitoring Board of the NIMH study Treating Depression and Insomnia (TRIAD). Listed in The Best Doctors in America and America's Top Doctors, he received an Exemplary Psychiatrist Award of the National Alliance for the Mentally Ill and two teaching awards at the University of Arizona.
|
|
Giannopoulou, Ioanna
Consultant Child and Adolescent Psychiatrist, NHS Community Mental Health Centre of Peristeri, Athens GREECE
|
Dr Ioanna Giannopoulou studied medicine at the University of Athens. She pursued her postgraduate studies in Addictions, with support of the Greek State Scholarships Foundation, at the Department of Psychiatry of the Huddinge University Hospital, Karolinska Institute (Sweden) from where she was granted the degree of M.Med.Sci. in psychiatry and then completed her training in psychiatry at the Maudsley and Bethlem Royal Hospitals (London). After becoming a Member of the Royal College of Psychiatrists (U.K.) she continued higher training in child and adolescent psychiatry. Following a successful research grant application to the Mental Health Foundation, she was appointed Clinical Research Fellow at the Academic Department of Child & Adolescent Psychiatry at the Institute of Psychiatry in London (U.K.). She completed her PhD thesis "Preschool hyperactivity: Development of observational and self-regulation measures for detecting hyperkinetic disorder in preschool children", under supervision of Professor Eric Taylor, at the Institute of Psychiatry, University of London. In 1997 she was appointed Consultant Child and Adolescent Psychiatrist at the NHS Community Mental Health Centre of Peristeri and since 2007 has been sharing her clinical time between Peristeri CMHS and the 2nd Department of Psychiatry at the "Attikon" University Hospital. Her varied research and clinical interests include ADHD, training parents in management techniques, fostering and adoption, risk and needs assessment. Much of her time has been devoted recently to studies examining psychological effects in children following exposure to trauma (earthquake, bush fires, school bus accident) and effective treatment interventions for the survivors. She has published papers on the related to her interests' topics, in Greek and English, in the form of journal articles and book chapters.
|
|
Goigolea, Jose
Psychiatrist, Bipolar Disorders Program of the Hospital Clinic, Barcelona, SPAIN
|
Dr. Jose M. Goikolea works as a psychiatrist at the Bipolar Disorders Program of the Hospital Clinic, at Barcelona. He attended Medical School at the University of the Basque Country in Spain, and then completed residency in Psychiatry at the Hospital Clínic in Barcelona. Since them, he has worked at the Bipolar Disorders Program in that hospital, headed by Dr. E. Vieta. He has combined a good deal of clinical work with research, mainly focused on novel treatments, both psychological and pharmachological, including atypical antipsychotics, novel antiepileptic drugs and ECT. He is currently leading a research project in first-episode mania. He has co-authored more than 30 articles and several book chapters. In 2005, he received the "Young Minds Award" by the American Psychiatric Association.
|
|
Gonda, Xenia
Clinical psychologist and pharmacist, Faculty of Medicine, Semmelweis University, Budapest, HUNGARY
|
Xenia Gonda MA PharmD PhD is a clinical psychologist and pharmacist working at the Department of Clinical and Theoretical Mental Health and Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University Budapest. Her main research interests include personality genetics, neurochemical and genetic correlates of suicidal behaviour and the association of mood states with the fluctuation of reproductive hormone levels.
|
|
Hantouche, Elie
Director of CTAH, Anxiety and Mood Center, FRANCE
|
Dr Hantouche is considered as top expert for bipolar disorders and OCD. He is also involved to be the scientific advisor of the French Association of Patients with OCD, and the National Union of Depressive and Manic Depressive Patients. Currently, Dr Hantouche is the director of CTAH, Anxiety and Mood Center. He has published more than 200 papers (64 cited in Pubmed*) and he is the author of 10 books on OCD, Cyclothymia, Bipolar OCD, Juvenile bipolarity, Creativity, Psychoeducation for Cyclothymia, Trilogy of fears and phobias. In April 2005, he chaired the 5th International Experts Meeting for Bipolar Disorders and launched the European Bipolar Forum - He is co-editor in chief of a new journal "Aspects of Affect" dedicated to Bipolar Disorders and reviewer for many international journals
|
|
Hauser, Peter
VISN 22 Mental Health Services Lead, Long Beach VA Medical Center, Long Beach, California, USA
|
Dr Hauser was born in Petersburg Virginia. His parents immigrated to the United States from what is now the Czech Republic in the 1950's. Dr Hauser graduated from the University of Virginia with a major in German Literature and then attended the University of Virginia Medical School. He began his psychiatry residency at the Clarke Institute of Psychiatry, University of Toronto and completed his last year of psychiatry residency at Georgetown University in Washington, DC. He then worked at the National Institutes of Health from 1986 until joining the Department of Veteran Affairs (VA) in 1994.
His VA career started in 1994 as the Chief of Psychiatry at the Baltimore VA Medical Center. In 2000 he became the Clinical Director of the Mental Health Division and the Chief of Psychiatry at the Portland VA Medical Center in Oregon and professor in the Departments of Behavioral Neurosciences, Internal Medicine and Psychiatry at the Oregon Health and Sciences University. He was also the Associate Director of the VA Northwest Hepatitis C Resource Center, one of 4 centers in USA dedicated to the treatment of veterans with hepatitis C.
Dr Hauser has served as a member of various VA national committees including the National Committee for Veterans Affairs Major Depressive Disorders Clinical Guidelines, the Department of Defense/Veterans Affairs Practice Guideline Major Depressive Disorders Working Group, the National Committee for Veterans Affairs Psychosis Clinical Guidelines and more recently the Joint Biomedical Laboratory Research and Development as well as the Clinical Science Research and Development Services Scientific Merit Review Boards. He is currently the VISN 22 Mental Health Services Lead in Long Beach, California.
Other accomplishments include his work as a psychiatrist and researcher in the public sector since 1986. His primary research and clinical interests are the psychiatric and substance use disorders co-morbidities in veterans with hepatitis C, the development of educational products for veterans with hepatitis C as well as the healthcare providers who treat these patients, and the treatment and underlying causes of interferon-induced depression. He has edited two books, authored several chapters, and published over 90 articles and letters in journals such as Molecular Psychiatry, New England Journal of Medicine, Journal of Affective Disorders and Proceedings of the National Academy of Sciences; the primary focus of his publications has been hepatitis-c, mood disorders and psychoneuroendocrinology. He is dedicated to serving veterans of the United States of America.
He lives with his wife Cathy and their three children - Katia, Anika and Max- in Palos Verdes, California.
|
|
Höschl, Cyril
Professor of psychiatry and chairman, Prague Psychiatric Centre, CZECH REPUBLIC
|
Cyril Höschl, MD, DSc., FRCPsych., born on 12 November 1949 in Prague (Czechoslovakia).
He received his MUDr. (Doctor of Medicine) grade at the Charles University in Prague in 1974. He started his career in Psychiatric Research Institute (PRI) in Prague and later on at Charles University in Prague. His research interests included psychoneuroendocrinology, psychopharmacology and biological psychiatry. In 1984, prof. Höschl presented his original work on neuroendocrine tests in psychiatry at several Canadian universities. In 1985, he was lecturing at New York University on his pioneering studies on calcium channel blockers in the treatment of affective disorders.
He was elected the Dean of the Third Medical Faculty of the Charles University in Prague (1990-1997) and appointed professor of psychiatry and chairman, Prague Psychiatric Centre. He is fellow of the Royal College of Psychiatry, the Past President of the European Psychiatric Association,
the President of the Czech Medical Academy and the President of the Federation of European Medical Academies and a member of many other societies
He has received several prestigious awards. He published more than 100 publications, incl. 3 monographs, and co-edited 5 more monographs and textbooks.
|
|
Janca, Aleksandar
Head of School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, AUSTRALIA.
|
University of Western Australia in Perth. He also works as a Consultant Psychiatrist at Royal Perth Hospital and is Director of the WHO Collaborating Centre in Perth. Prof. Janca started his research career in 1987 as a Fulbright Scholar at the Department of Psychiatry, Washington University School of Medicine in St Louis, Missouri. From 1991 to 1997 he worked as a Medical Officer at WHO Headquarters in Geneva and was responsible for coordination of a number of international projects in the areas of psychiatric nosology, psychiatric epidemiology and transcultural psychiatry. Prof. Janca has a particular interest in the development and evaluation of novel psychiatric assessment instruments and outcome measures
|
|
Kahl, Kai
Executive director, Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, GERMANY
|
Prof. Elie Karam founded IDRAAC (Institute for Development, Research, Advocacy and Applied Care) in 1982 and is currently the institution's Executive Director. IDRAAC is an institute solely devoted to Research and Field Services in Mental Health. (www.idraac.org). IDRAAC's research has addressed a variety of important regional and international issues such as violence (including war), depression, suicide, substance abuse, childhood disorders, burden and treatment of mental health disorders, temperament etc… and is the training center for CIDI for the Arab World.
In addition to the researches outlined above, prof. Elie Karam initiated the first national study on mental health in the Arab World - Lebanese Evaluation of the Burden of Ailments and Needs Of the Nation (L.E.B.A.N.O.N.). He is member of several national and international societies. He is on the Editorial Board of several international journals. He has published several articles. Prof. Elie Karam founded MIND (Medical Institute for Neuropsychological Disorders) in 1985. MIND clinics are best known for this multi-specialist approach delivered by experts in the field of psychiatry, psychology, social work and nursing and has specialists in Child / Adolescent, Adult and Geriatric Mental Health. MIND clinics are equipped with the knowledge, expertise and resources to assess, evaluate and treat every psychiatric and psychological disorder including ADHD, substance use, memory problems, depression, anxiety, bipolar, PTSD, phobias, schizophrenia, eating disorders, sexual dysfunction, delusions, stress etc. (www.mindclinics.org).
|
|
Kargopoulos, Filippos
Associate professor of Logic and Philosophy of Mind, Psychology Department, Aristotle University of Thessaloniki, GREECE
|
Dr. Awad is a professor emeritus in the Department of Psychiatry, and on the Faculty of the School of Graduate Studies in the Institute of Medical Science, University of Toronto. He also serves as the Psychiatrist in Chief of the Department of Psychiatry and Mental Health at Humber River Regional Hospital in Toronto. Dr. Awad continues to serve as a national and international reviewer and consultant for academic and service programs. He also serves in several national and international organizations, including recently being elected as the first Founding President of the newly developed International Society for CNS Clinical Trails and Methodology (ISCTM). He also served as the eleventh president of the Canadian College of Neuropsychopharmacology. He chaired and served on a number of NIH, NIMH, CINP committees. He continues to serve as a member of the International Advisory Board to the German federal government, which oversees the network of Schizophrenia Centres of Excellence in Germany. Dr. Awad made significant contributions to the Canadian Psychiatric Research Foundation, having chaired its Professional Advisory Board for a number of years and was instrumental with support from the Tanenbaum family to establish the Tanenbaum Distinguished Scientist Award in Schizophrenia. Dr. Awad was honoured to receive such an award in 1998. In 2000, he was also awarded the Canadian College of Neuropsychopharmacology medal for meritorious contributions in psychopharmacology research, teaching and services. Dr. Awad is recognized for his national and international contributions that has led to significant research development in such areas as quality of life, subjective tolerability to medications and patient reported outcomes, and outcomes research in general.
|
|
Kasper, Siegfried
Professor and Chair, Department of Psychiatry and Psychotherapy, Medical University of Vienna, AUSTRIA
|
Dr. Kasper published 724 in ISI (http://portal.isiknowledge.com) listed publications (Citation Index: 6989, Hirsch-Index: 43) and more than 200 book chapters, in various areas of psychiatry. Dr. Kasper serves on the executive committees and advisory boards of several national and international societies, such as the European College of Neuropsychopharmacology (ECNP) and the Collegium Internationale Neuro-Psychopharmacologicum (CINP). He is president of the Austrian Society of Drug Safety in Psychiatry (ÖAMSP) and past-president of the Austrian Society of Neuropsychopharmacology and Biological Psychiatry (ÖGPB). Furthermore, he is an honorary member of the Czech and Romanian Societies of Neuropsychopharmacology, the Hungarian Psychiatric Association and a Fellow of the Royal College of Psychiatrists, UK, as well as of the Ukrainian Association of Psychiatry. In 1997, he was the president of the 10th ECNP Congress, was the chairman of the local organizing committee of the WPA Thematic Conference in 2004 and is the co-chair of the local organizing committee of the WFSBP Congress 2005 in Vienna. Furthermore, he has been appointed honorary Professor at the University of Hong Kong, China. Dr. Kasper has been elected as President of the World Federation of Societies of Biological Psychiatry (WFSBP) for the term 2005-2009. Dr Kasper serves on editorial boards of numerous learned journals (total 51), including Journal of Clinical Psychiatry, European Archives of Psychiatry and Neuroscience, Comprehensive Psychiatry, and European Neuropsychopharmacology. He is Co-Editor-in-Chief of the International Journal of Psychiatry in Clinical Practice, Editor of the World Journal of Biological Psychiatry, and Field Editor of the International Journal of Neuropsychopharmacology.
|
|
Kastrup, Marian
Head, Centre for Transcultural Psychiatry, Psychiatric. Dept. Rigshospitalet, Copenhagen University Hospital, DENMARK
|
Dr Kastrup received her medical degree in 1973 from the University of Aarhus, Denmark. In 1975 she received the Gold Medal Award in Psychiatry from the University of Odense, in 1983 her Ph.D from the University of Copenhagen, and in 1985 her specialty in Psychiatry from the Danish National Board of Health. Since 2001 she directs the Centre for Transcultural Psychiatry, Psychiatric. Dept. Rigshospitalet, Copenhagen University Hospital, Denmark. From 1992-8 was Associate Professor in Psychiatry, University of Copenhagen and currently is External examiner in Psychiatry, MPH programmes and Bachelor of Public Health, Universities of Copenhagen, Aarhus and Odense, External examiner, University of Odense, External examiner in Psychiatry, University of Copenhagen. She served in various advisory positions of the WHO, the EPA and the WPA among others. She is author/co-author of more than 90 peer-review articles, editor/author of more than 15 books and more than 60 book-chapters and more than 60 technical reports/other publications.
|
|
Kokkas, Basileios
Professor of Pharmacology and Head of the 1st Department of the Experimental Pharmacology, School of Medicine, Aristotle University of Thessaloniki, GREECE
|
Dr Kokkas was born in Chalkida Greece in 1944. He obtained his medical degree from the Medical Faculty, Aristotle University of Thessaloniki, Greece in 1969 and was specialized in Radiology in 1975. His post-graduate training at the Université Libre de Bruxelles includes six months of pharmacological research in the field of the vascular wall (Institut de Recherche Interdisciplinaire en Biology Humaine et Nucleaire; 1987), one month of intensive information, as a visitor professor, in the use of the Positron Emission Tomography in the pharmacological research (Hopital Erasme, Services de Medecine Nucleaire; 1989), six months training in therapeutic drug monitoring (Hopital Erasme, Services de Chimie Medicale; 1997) and 193 hours of intensive sessions concerning the whole studies that must be carried for the development and the marketing of a new drug (PHARMED Seminars, Post-Graduate Programme in Pharmacology and Pharmaceutical Medicine; 1997) He is author or co-author of more than 200 published articles, of which 41 in international journals and 5 books.
|
|
Konstantinidis, Anastasios
University Hospital for Psychiatry and Psychotherapy, Clinical Division for Biological Psychiatry, Vienna, AUSTRIA
|
Born 1974 in Thessaloniki, Greece, studied medicine and accomplished medical training in psychiatry in the Medical University of Vienna (MUV). Since 2001 working in the Clinical Division for Biological Psychiatry in Vienna. Main scientific area is psychotropic treatment of psychiatric disorders (including Tourette Syndrome, ADHD in Adults, Recurrent Brief Depression, Seasonal Affective Disorder among others) and more specifically psychotropic polypharmacy and pharmacovigilance in psychiatry (drug safety / drug surveillance). He already published as author and co-author many studies in journals such as Biological Psychiatry, Archives of General Psychiatry or European Neuropsychopharmacology. He also functioned as monitor for imaging studies of his division. He already took part in numerous national and international psychiatry congresses. Recently he was invited to give a speech in the International Congress of the International Society of Pharmacovigilance in Buenos Aires, Argentina.
|
|
Koukopoulos, Athanasios
Director of the Centro Lucio Bini, Rome ITALY
|
At present director of the Centro Lucio Bini, a center for the treatment and study of psychiatric conditions, particularly affective disorders, that he and other colleagues founded in 1970. In 1977, he founded the Centro Lucio Bini in Cagliari with Dr. Leonardo Tondo. From 1963 to 1998 he was the Head of the medical staff of the Clinica Belvedere Montello, a private psychiatric in-patient facility in Rome.
His main activity has always been the examination and treatment of psychiatric patients with a particular interest in Affective Disorders. In addition to his clinical activity, he has been performing some clinical research on the course of Manic-Depressive Illness, the pattern of the manic-depressive cycle and the effects of the treatments upon it.
He is also conducting studies on manic-depressive temperament and its importance in the genesis of affective disorders and their course.
Related to the above issues have been the lines of research on the response to prophylactic lithium treatment and the increase of bipolarity and frequency of recurrences following antidepressant drug treatments. The temperement, the course and the concomitant factors of rapid cyclicity have been an important part of his work for more than thirty years. For more than twenty years he has been working on agitated and mixed depression arguing that they are mixed states often induced by antidepressants and requiring a different treatment. His last work was on the "Primacy of Mania" hypothesis i.e manic and hypomanic states should be considered primary and depression would be the consequence of these excitatory processes. The prevention and treatment of the excitatory phases should be considered the focus of prophylaxis.
|
|
Koupidis, Sotirios
Deputy CEO, Dromokaiteion Psychiatric Hospital of Athens, GREECE
|
Dr Koupidis was born in 1975 in Veroia, graduated from the Aristotle University of Thessaloniki School of Medicine and the National School of Public Health, and currently works on his PhD at the University of Athens School of Medicine
He serves since 2008 as chair of the Social Collective 'New Horizons' Ltd, who creates employment positions for mental patients. He is also vice chair of the Greek Rescue Team in Imathia county.
He served as deputy CEO of the Psychiatric Hospital of Chania (2005), CEO of the Psychiatric Hospital of Corfu (2005-8) and since 2008 as deputy CEO at the Dromokaiteion Psychiatric Hospital of Athens.
Currently is administrative coordinator of the Administration Task force of the Ministry of Health for the first nation-wide epidemiological surveys for mental disorders in children, adolescents and adults.
He has received awards twice for the most important administrative work, on issues concerning the improvement of functioning of mental health services. Also, he has received an honorary scholarship for his excellence in his studies at the department of Health Units Administration studies at the Kalamata TEI.
|
|
Küey, Levent
Secretary General, World Psychiatric Association
Associate Professor of Psychiatry, Istanbul TURKEY
|
Born in 1957; Medical Doctor in 1981; Specialist of Psychiatry in 1985; Associate Professor of Psychiatry in 1989; Assistant Therapist in Psychodrama Group Psychotherapy in 1993. Work, research and teaching experiences for nearly 30 years in different psychiatric institutional settings, currently practicing, teaching and supervising in Psychology Department of Istanbul Bilgi University and in private practice. Main fields of research and publication are depressive and anxiety disorders, psychiatric epidemiology, case formulation, social and cultural psychiatry, psychopathology, diagnosis and classification. Author of over 50 scientific journal articles. Author and translator of numerous books and book chapters. Research award of the Turkish Journal of Psychiatry, in 1997. Past editor and current member of the scientific board of the leading national and some international journals of psychiatry. Founder member and past Executive Committee member of the Psychiatric Association of Turkey. Past member of the Honorary Board of the Turkish Medical Association-Izmir Branch. Honorary Member of WPA; Member of the WPA Sections on Classification and Diagnossis and Public Policy and Psychiatry; Co-chair of the WPA Standing Committee on Planning. A co-opted member of the European Division of the Royal College of Psychiatrists, UK. Member of the Evaluation Committee in Psychiatry for the UEMS-EACCME (European Union of Medical Specialists-European Accreditation Council for Continuing Medical Education). Secretary General and/or Organizing and Scientific Committee Member in nearly 40 national and international scientific meetings. Lecturer/speaker at over 40 international and 50 national scientific meetings.
|
|
Lieberman, Daniel
Associate Professor and Director of Research in the Department of Psychiatry and Behavioral Sciences at George Washington University in Washington, DC, USA
|
Dr Lieberman is Associate Professor and Director of Research in the Department of Psychiatry and Behavioral Sciences at George Washington University in Washington, DC. He also chairs the university's institutional review board. Dr. Lieberman did his undergraduate work at Saint John's College in Annapolis, Maryland, and attended medical school and did his residency training at New York University. He has been on the faculty of George Washington University since 1996.Dr. Lieberman is active in research, teaching, and patient care. His research has focused on using the Internet to expand access to psychosocial interventions. He developed a Web application for drinkers that mimicked a motivational intervention by providing assessment feedback, allowing the user to identify positive and negative consequences of substance use, and providing direct advice when indicated. This application was able to increase treatment interest in a hidden population of alcohol abusers who were not accessing traditional forms of care. Currently he is working on an open source Web application and iPhone app that makes daily mood charting easier to maintain long term.
|
|
Lykouras, Lefteris
Professor of Psychiatry, Director of the 2nd Department of Psychiatry, Attikon Hospital, School of Medicine, Athens University, GREECE
|
Professor Lykouras was born in Piraeus Greece, graduated from the Athens University School of Medicine in 1969 and completed his residency in Neurology and Psychiatry in 1975. He completed his PhD in 1981 and a post-doctorate appointment in 1988. He speaks Greek English and French. He received a Doctoral dissertation scholarship (1974-1975) and a Post-doctoral research scholarship (1978-1981). He was appointed Lecturer in Psychiatry, in 1982, Senior Lecturer in Psychiatry, in 1988, Reader in Psychiatry, in 1996 and Profesor in Psychiatry, School of Medicine Athens University in 2004. He is member of a significant number of national and international scientific societies and participated in the organization of congresses and was invited speaker chairman of session or participant in more than 150 scientific events. He acts are regular reviewer in international journals and is active in the research in Clinical Psychiatry, Biological Psychiatry and Psychopharmacology General Hospital Psychiatry, and Psychiatric Education. He has authored or co-authores more than 500 journal articles and abstracts, received more than 1.000 citations and 10 books
|
|
Malliaris, Yianni
Department of Health Service and Population Research, Institute of Psychiatry, King's College London, London, UNITED KINGDOM
|
Yanni Malliaris, BSc. graduated from Stirling University and UCLA with a first class honours degree in Psychology in 1999. During his undergraduate years he developed an interest in the psychosocial factors of affective disorders by studying with Professor Constance Hammen and trained in behaviour modification with Professor Ivar Lovaas. Since completing his military service (2002) he has been working as a research psychologist at the Institute of psychiatry, King's College London, where he is also currently completing his PhD thesis under the supervision of Professors Dinesh Bhugra and Tom Craig. At the Institute, he began his work with Professor Dominic Lam and commenced his own research project (www.bipolarlab.com) following funding from the Medical Research Council. Yanni is exploring the impact of sub-syndromal symptoms in the course of Bipolar disorder and particularly the role of symptom variability in predicting relapse. He is also studying the role of new technologies for tracking the variable course of Bipolar disorder. Yanni is a firm believer in the positive role of self-help organisations and over the last year has founded the Hellenic Bipolar Organisation (www.bipolar.gr), the first NGO for bipolar patients in Greece, in his father's memory.
|
|
Malliori, Meni
Assistant Professor of Psychiatry, University of Athens Medical School, GREECE
|
Dr Malliori was born in Patras Greece in 1952, graduated in 1978 from Athens University Medical School and after residency in psychiatry had her post-doctoral training in the Tavistock Clinic London, the Nottingham University and the World Health Organization (WHO), Geneva, in the fields of Mental Health Services Planning, State Psychiatric Services, organizational structure, planning and implementation on drug policy (1979-1984). During 1987 was Consultant in the Mental Health Department of the World Health Organization (WHO), Geneva and from 1987-1997 served as consul to the Minister of Health and responsible for the psychiatric transformation, the closure of big asylums and the social rehabilitation of mental patients During 1997-1999 she served as head of the Organization Against Drug Abuse (OKANA) and during 1999-2004 served as member of the European Parliament and member of the Committee for Public Health, Environment and Consumers Protection. Since 2004 she served as Deputy Chair in the Management Board of the European Centre for Prevention and Control of Diseases (ECDC). Since 2006 she served as member of the Experts Committee for the Health Consumer Powerhouse, for the Code for the Assessment of Health Services. She has also served as member of the Steering Committee for evaluation of the actions undertaken within the framework of the European Community Public Health Program related to the fight against cancer, drugs, AIDS and other communicable diseases, member of the Scientific Committee of the Regional Congress of the World Psychiatric Association in Preventive Psychiatry and since 2008 is member of the Work Group of the European Parliament for Mental Health and Drug Abuse. Her research activity includes publication on the topic of Mental Public Health, Drug Abuse, Consumers Safety and Protection and Environmental Issues
|
|
Mandelli, Laura
Lecturer in psychiatry, Institute of Psychiatry, University of Bologna and Assistant Professor of Psychiatric Genetics, University of Molise, Campobasso, ITALY
|
Laura Mandelli was born in August 13, 1976. She has participated in several national and international research programmes in psychiatry, including projects funded by the European Commission and the Italian Ministry for Research. An invited member of the European College of Neuropsychopharmacology and reviewer for more than 10 international scientific journals, Laura Mandelli has more than 55 peer-reviewed published articles. In the past, she received several prizes as a Young Scientist, including the ECNP fellowship award in 2007 and the CINP Rafaelsen award in 2008.
|
|
Mironidou-Tzouveleki, Maria
Associate Professor of Pharmacology, A' Department of Pharmacology, Medical School, Aristotle University of Thessaloniki, GREECE.
|
Prof. Mironidou-Tzouveleki studied Medicine and Italian Language and Literature at the Aristotle University of Thessaloniki, Greece. In 1981 she completed her specialization in Anaesthesiology. Since 1982 she has been working and teaching at the Medical School, Aristotle University of Thessaloniki, Greece. Currently she is an an Associate Professor at the A' Department of Pharmacology of the Medical School, where she does teaching and research in general, molecular and clinical pharmacology. Moreover, she organizes and/or participates in other under- und postgraduate programs of the Medical School, with lectures regarding pharmacology, evidence based medicine and research methods. Her scientific fields of interest include pharmacology of pain, molecular pharmacology of inflammation and the role of ÍÏ, pharmacology of drug and of contrast media, wound healing, history of Medicine, as well as the translation of I. Papafis archives from Italian into Greek. She has contributed in 6 books and over 300 papers and is member of many Greek and international scientific organisations.
|
|
Möller, Hans-Jurgen
Professor of psychiatry and chairman of the Psychiatric Department, Ludwig-Maximilians University, Munich, GERMANY.
|
Hans-Jürgen Möller has been working in the field of psychiatry for 30 years. After obtaining his Doctor of Medical Science in 1972 from the Universities of Göttingen and Hamburg, Germany, he then specialised in psychiatry and postgraduate training at the Max Planck Institute of Psychiatry in Munich. Professor Möller completed a postdoctoral thesis (habilitation) in psychiatry in 1979. From 1980 to 1988 he was professor of psychiatry at Munich Technical University, and from 1988 to 1994 full professor of psychiatry and chairman of the Psychiatric Department at the University Bonn, Bonn, Germany.
Professor Möller's main scientific contributions include clinical and neurobiological research into psychiatry, schizophrenia and depression and clinical psychopharmacology. He has been a member of the boards (executive committees) of several national and international psychiatric societies. Currently, he is president of the European Psychiatric Association (EPA). He serves as chairman of the Section on Pharmacopsychiatry of the World Psychiatric Association (WPA). For two years he has been a member of the executive committee of the Collegium Internationale Neuro-Psychopharmacologicum (CINP), where he is now president-elect. From 1997 to 2001 he was president of the World Federation of Societies of Biological Psychiatry (WFSBP), where he is now honorary president.
In addition to authoring and co-authoring over 1000 international publications and several books, he is also chief editor of The World Journal of Biological Psychiatry, main editor of European Archives of Psychiatry and Clinical Neuroscience, and editor of two psychiatric journals, Nervenarzt and Psychopharmakotherapie. He holds positions on the editorial boards of numerous national and international psychiatric journals.
In 2008 Professor Möller was awarded the prestigious Jean Delay Prize from the World Psychiatric Association.
|
|
Molyva, Dimitra
Doctoral student and academic associate at the Department of Pharmacology, School of Medicine of Aristotle University Thessaloniki, GREECE
|
Dimitra Molyva was born in 1979 in Thessaloniki, Greece. She attended Royal Holloway, University of London where she completed a BSc in Biology in 2000. In 2001 she received an MSc in Cognitive Neuroscience from Imperial College London. Since 2003 she has been studying Medicine at the School of Medicine of Aristotle University Thessaloniki. Since 2005 she has been a doctoral student and an academic associate at the Department of Pharmacology in said School. Her research interests include neuroscience, genetics, pharmacogenetics, and pharmacology of inflammation. She is co-author of 12 refereed publications and 19 abstracts and has received 76 citations.
|
|
Morasco, Benjamin
Assistant Professor, Department of Psychiatry at Oregon Health & Science University, Portland, Oregon, USA
|
Dr. Benjamin Morasco is an Assistant Professor in the Department of Psychiatry at Oregon Health & Science University, a Staff Psychologist at the Portland VA Medical Center, and a member of the Northwest Hepatitis C Resource Center, in Portland, Oregon. He earned a doctorate in clinical psychology from Saint Louis University in 2003, and went on to complete postdoctoral fellowships in health psychology and in addictive behaviors. His research is currently funded by the National Institute on Drug Abuse to examine issues of chronic pain and substance use in patients with the hepatitis C virus.
|
|
Moussaoui, Driss
Professor of Psychiatry and Psychological Medicine and chairman of the Ibn Rushd University Psychiatric Centre in Casablanca, MOROCCO.
|
Dr. Driss Moussaoui is professor of Psychiatry and Psychological Medicine. In 1979, he founded and is still the chairman of the Ibn Rushd University Psychiatric Centre in Casablanca, Morocco, which is a WHO Collaborating Centre in Mental Health and Neurosciences since 1992.
Dr. Moussaoui is past-president of the Moroccan Society of Psychiatry and of the Arab Federation of Psychiatrists. He was also member of the executive committees of the World Association for Social Psychiatry and of the World Federation of Societies of Biological Psychiatry. He was honoured as "Knight of Throne Wissam" of the Kingdom of Morocco and he received the Prize of the President of Tunisia in Medicine.
Dr. Moussaoui founded or co-founded a number of associations in the fields of Psychiatry and Mental Health in Morocco, in the Maghrebian countries, and on the international scene. He published more than 100 articles in international journals and chapters of books. Dr. Moussaoui is member of the editorial board of a number of international journals. He also wrote or edited 10 books.
Dr. Moussaoui worked closely with the World Psychiatric Association (WPA) since 1981. He participated in 1990 to the WPA Visiting Team to USSR, investigating possible political abuse of psychiatry. He was WPA Regional Representative for North Africa and the Middle East from 1993 to 1996 and Secretary for Meetings from 1996 to 2002. He was chairman of the WPA Section on Education in Psychiatry. In this respect, he contributed to the development of many WPA educational programs (Core curriculum in psychiatry for undergraduates, Core curriculum for post-graduates, WPA bulletin on depression, Teaching and learning about schizophrenia, Fighting schizophrenia and its stigma, Depressive disorders).
Dr. Moussaoui initiated and implemented a number of WPA programmes: the Programme for Libraries in Developing Countries, the series "Anthologies of World Psychiatry" of which he is the director (so far from French, Spanish, and Italian and German into English; Greek anthology is in preparation). He also initiated the WPA Jean Delay Prize (40,000 €), the highest of its kind in psychiatry, which awards a person or an institution, who helped best bridging the gap between the biological and the psycho-social aspects of psychiatry.
Dr. Moussaoui was elected member of the French Academy of Medicine in 2007.
He is also currently President-Elect of the World Association for Social Psychiatry (WASP) in 2007.
Dr. Driss Moussaoui was born in 1949 and is father of 3 children.
|
|
Papaioannidou, Paraskevi
Associate Professor of Pharmacology, 1st Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, GREECE
|
Paraskevi Papaioannidou graduated in Chemistry and Medicine at the Aristotle University of Thessaloniki, has a Ph.D. in Pharmacology, post-graduate education in the Department of Pharmacology, Ìedical Faculty, University of Alberta, Canada, and a post-doctoral education in Gas Chromatography, in Unicam Laboratories, Cambridge, UK. She was a visiting researcher in the 1st Clinic of Obstetrics and Gynecology (Division of Assisted Reproduction, Sant' Orsola Hospital) in Ìedical Faculty of the University of Bologna for one year. She has been an invited lecturer and researcher in the Department of Pharmacology, Clinical Pharmacology and Toxicology, of the Faculty of Ìedicine in the University of Novi Sad, and in the Department of Pharmacology and Clinical Pharmacology of the Faculty of Ìedicine in the University of Kragujevac.
She has published more than 200 articles in peer review journals on Antimicrobial Chemotherapy, Reproductive Pharmacology, Gender related Pharmacology, Sexual differentiation of the brain, Prostaglandins and Drug Interactions. She has created and is the co-ordinator of two European research networks supported by the Aristotle University: follicle net (website: folliclenet.web.auth.gr) and AntibioSurv (website: antibiosurv.web.auth.gr). She is reviewer in peer review international journals and Congresses and has been invited speaker in International Congresses. She has organized and is the coordinator of medical and interdisciplinary institutional and inter-institutional post-graduate programs.
She has organized and participated in many multicentric European and international research projects. She is the organizer and leader of ASPPOC (a multicentric European project with participation of 40 Surgery and Pharmacology Departments from 12 countries), she has participated in SIG-DUR (an international multicentric study of ÉSPE on cross-national comparison of Drug Utilization, with the participation of 24 countries), and she had a collaboration with ÍÉÇ, Bethesda, USA. One of her PhD students has received the Milton Huppert Graduate Student Award of the Medical Mycological Society of the Americans (May 2007, Toronto, Canada).
|
|
Perrin, Raymond
Honorary Senior Lecturer at the School of Public Health and Clinical Sciences, UCLAN, UNITED KINDGOM
|
Dr Raymond Perrin is Honorary Senior Lecturer at the School of Public Health and Clinical Sciences, UCLAN and a Registered Osteopath and Specialist in Chronic Fatigue Syndrome. He is Director of The Perrin Clinic Ltd., Research Director of F.O.R.M.E. Trust, and Visiting Lecturer at The British School Of Osteopathy, London. He has held the positions of Honorary Advisor to the Northern Branch of The International Spinal Research Trust (1985-1990) and Official Osteopath to the World Student Games, Sheffield (1999). He obtained his D.O. at The British School of Osteopathy, London (1984) and his Ph.D. Biosciences, The University of Salford (2005). Dr. Perrin has lectured extensively internationally and has published medical and scientific papers on chronic fatigue syndrome/myalgic encephalomyelitis. He is the author of the book The Perrin Technique (2007).
|
|
Perugi, Giulio
Professor of Clinical Psychiatry and Psychopharmacotherapy, University of Pisa, ITALY
|
Giulio Perugi, MD, received his medical degree at the University of Pisa in 1981 and he was trained in Psychiatry until 1985. He works as the co-director of the Day-Hospital unit of the Department of Psychiatry of the University of Pisa. Dr Giulio Perugi is professor of Clinical Psychiatry and Psychopharmacotherapy at the University of Pisa, Italy. From December 2000, Dr Perugi is the director of the Institute of Behavioural Sciences "G.Delisio", in Pisa. He is involved in the International Research Project on Mood Disorders in collaboration with the University of South California at San Diego. In this field he has developed and directed many research projects on Mixed States, Mania, Anxious-Bipolar Co-morbidity and Atypical Depression-Bipolar II-Borderline connection. In the field of anxiety disorders he has directed several studies on clinical features and long-term naturalistic treatment of Panic Disorder-Agoraphobia, Obsessive-Compulsive Disorder and Social Phobia. He is part of the editorial board of the Journal of Affective Disorder and other 5 International Journals. He is the author of 3 books and over 350 papers, published in national and international Journals (about 120 peer reviewed), on psychopathology, clinical psychopharmacology, and pharmacotherapy of affective disorders.
|
|
Pi, Edmond
Associate Chair for Clinical Affairs, Professor of Clinical Psychiatry, University of Southern California (USC) Keck School of Medicine and Director of Psychiatric Consultation and Liaison Service (Psychosomatic Medicine), Los Angeles County and USC Medical Center, USA.
|
Edmond Hsin-tung Pi, M.D. has outstanding achievements in clinical care, teaching, research, and administration. He has been included in "The Best Doctors in America" since 1994. He is also a Visiting Professor of Psychiatry at the Tsinghua University in Beijing, China. Dr. Pi is an accomplished researcher in the field of cross-cultural psychiatry, psychopharmacology, and movement disorders, with more than 150 publications and one book. He was honored as the recipient of the 2009 Asian American (Kun-po Soo) Award of the American Psychiatric Association (APA). Dr. Pi has been very active on both the US and the international scenes in the field of psychiatry including serving as President of the Association of Chinese American Psychiatrists; Member of the International Advisory Committee of World Psychiatric Association (WPA) Regional Meetings, the Pacific Rim College of Psychiatrists Scientific Meeting, and the Latin American Psychiatric Congress; Member of the Organizing-Liaison Committee of the First World Congress of Cultural Psychiatry; Member of the Scientific Program Committee of the APA. Dr. Pi has held substantial administrative positions over the last 30 years including serving as the Medical Director of the Department of Mental Health (DMH), State of California, the most populous state in the USA with 32 million residents. The DMH had oversight over almost $2 billion public mental health annual budget and Dr. Pi was the Department's highest level psychiatrist.
|
|
Pilling, Stephen
Director of the Centre for Outcomes Research and Effectiveness, Research Department of Clinical, Health and Educational Psychology, University College London, UNITED KINGDOM
|
Stephen Pilling PhD is a clinical psychologist and Director of the Centre for Outcomes Research and Effectiveness in the Research Department of Clinical, Health and Educational Psychology at University College London. He is also the Joint Director of the National Collaborating Centre for Mental Health which produces clinical practice guidelines in mental health for the UK National Institute for Health and Clinical Excellence (NICE). He has interest in the development and evaluation of psychological treatments for depression and oversees a training programme in low intensity cognitive behavioural interventions for common mental disorders. He has been a consultant advisor to the UK Department of Health where he worked to establish the Mental Health Research Network, a UK wide research network. He has published extensively in the areas of clinical guidelines, health service research and most recently in the development of competence frameworks for psychological therapists.
|
|
Puri, Basand
Professor of Psychiatry, Imperial College London, UNITED KINGDOM
|
Professor Basant K. Puri received his primary and postgraduate degrees in medicine from the University of Cambridge, and carried out post-doctoral work in molecular genetics at the University of Cambridge and in imaging at the Royal Postgraduate Medical School at Hammersmith Hospital, London. He also has postgraduate degrees in mathematics and is a member of the Royal College of Psychiatrists. While at Hammersmith Hospital and the MRC he contributed to our understanding of the effects of lipids on brain structure and chemistry and directed a clinical programme to study the effects of lipids on major neurological and psychiatric disorders. He demonstrated the benefits of lipids on the clinical symptomatology and cerebral atrophy of Huntington's disease, and has helped develop methods to quantify the effects of PUFAs on brain structure. He is the author of over 30 books and 150 papers.
|
|
Rihmer, Zoltán
Professor of psychiatry, Department of Psychiatry and Psychotherapy, and scientific director, Department of Clinical and Theoretical Mental Helath, Semmelweis University, Faculty of Medicine, Budapest, HUNGARY
|
Prof.. Zoltán Rihmer, Md, PhD, DSc, received his medical diploma in 1971. Since then he has been working at the National Institute for Psychiatry and Neurology, Budapest, Hungary. From 2007 he is professor of psychiatry at the Department of Psychiatry and Psychotherapy, and scientific director at the Department of Clinical and Theoretical Mental Helath, Semmelweis University, Faculty of Medicine, Budapest.
Dr. Rihmer has three special examinations: psychiatry (1976), neurology (1979) and clinical pharmacology (1990). He received his PhD at the Hungarian Academy of Sciences in 1993, and his DSc in 2004. His special interest is the clinical and biological aspects of mood and anxiety disorders, with particular regards to prediction of treatment response and prevention of suicide. He has published more than 350 scientific articles/book chapters (more than 180 in English) and four books. He received the Brickell Suicide Research Award of the Department of Child and Adolescent Psychiatry, Columbia University, New York, and the Life Achievement Award of the Hungarian Psychiatric Association. He is National Clinical Audit Lead in Psychiatry of Hungary. Professor Rihmer is a member of several Hungarian and international scientific boards and associations, including the editorial board of Journal of Affective Disorders, International Journal of Psychiatry in Clinical Practice, Neuropsychobiology and World Journal of Biological Psychiatry . He is also a member of the Executive Committee of the European College of Neuropsychopharmacology.
|
|
Rybakowski, Janus
Head of Department of Adult Psychiatry, University of Medical Sciences, Poznan, POLAND.
|
Prof. Rybakowski graduated in 1969 at Medical Academy Poznan, Poland. In 1976-77 he was NIH Fogarty Research Fellow at Department of Psychiatry, University of Pennsylvania, Philadelphia. In 1985-1995 he was Chairman, Department of Psychiatry, Medical Academy, Bydgoszcz, and since 1994, the Head of Department of Adult Psychiatry, University of Medical Sciences, Poznan, Poland.
Prof. Rybakowski has authored over 500 publications and serves on editorial boards of Neuropsychobiology, Bipolar Disorders, Pharmacopsychiatry, International Journal of Psychiatry in Clinical Practice, and Cardiovascular Psychiatry and Neurology.
Prof. Rybakowski was the President of Polish Psychiatric Association in 1998-2001, and Board Member of Association of European Psychiatrists in 1998-2004. Currently, he is a member of ECNP, CINP, Society of Biological Psychiatry, International Society of Bipolar Disorders, International Society of Psychiatric Genetics, International Society of Affective Disorders, International Neuropsychiatric Association, International Group for the Study of Lithium-Treated Patients, and European Group for the Research in Schizophrenia.
|
|
Samolis, Stavros
Psychiatrist NHS, Psychiatric Department, General Hospital of Thessaloniki 'Ippokratio', GREECE
|
Dr Samolis graduated from Medical school of the Aristotelian University of Thessaloniki. He underwent his residency in Psychiatry at the 3rd University Psychiatric Clinic of AHEPA Hospital. He has also 2,5 years of training in systemic family psychotherapy. After this he worked as specialist for three years at a private psychiatric clinic in North West Greece, being the doctor -in- charge of a department of the clinic. He currently works as psychiatrist of the National Health System at the Psychiatric department of General Hospital of Thessaloniki 'Ippokratio' performing outpatient unit and consultation- liaison services. He has participated as co-investigator in five phase III and IV pharmacological trials. He has participated in the authoring of several research works presented in congresses and published in journals. He is member of the Hellenic Psychiatric Association and the International Society of Quality in Clinical Practice. He is fluent in English.
|
|
Sartorius, Norman
Professor of Psychiatry, Geneva, SWITZERLAND
|
Dr Norman Sartorius, MD, MA, DPM, PhD, FRCPsych, obtained his M.D. in Zagreb (Croatia). He specialized in neurology and psychiatry and subsequently obtained a Masters Degree and a Doctorate in psychology (Ph.D.). He carried out clinical work and research and taught at graduate and postgraduate levels at the University of Zagreb, at the Institute of Psychiatry in London, at the University of Geneva and elsewhere. Dr Sartorius joined the World Health Organization (WHO) in 1967 and soon assumed charge of the programme of epidemiology and in social psychiatry. He was also principal investigator of several major international studies on schizophrenia, on depression and on health service delivery. In 1977, he was appointed Director of the Division of Mental Health of WHO, a position which he held until mid-1993. In June 1993 Professor Sartorius was elected President of the World Psychiatric Association (WPA) and served as President-elect and then President until August 1999. In January 1999, Professor Sartorius took up his functions as President of the Association of European Psychiatrists (AEP) and is now the President of the International Association for the Promotion of Mental Health Programmes and President of the Board of the Prize of Geneva Foundation. Dr Sartorius holds professorial appointments at the Universities of London, Prague and Zagreb and at several other universities in the USA and China. He is a Senior Associate of the Faculty of the Johns Hopkins School of Public Health in Baltimore, Maryland. Professor Sartorius has published more than 300 articles in scientific journals, authored or co-authored several books and edited a number of others. Professor Sartorius is a corresponding member of the Croatian Academy of Arts and Sciences and a Corresponding Member of the Spanish Royal Academy of Medicine and of the Medical Academies of Peru and Mexico. He is a Doctor of Medicine Honoris Causa of the Universities of Umea and of Prague and a Doctor of Science Honoris Causa of the University of Bath. He is an Honorary Fellow of the Royal College of Psychiatrists of the United Kingdom of Great Britain and of the Royal Australian and New Zealand College of Psychiatrists. He is also a Distinguished Fellow of the American Psychiatric Association. He is an Honorary Member of numerous professional associations and advisory boards, both national and international. He is also the Co-editor of three journals and a member of editorial and advisory boards of many scientific journals. He speaks Croatian, English, French, German, Russian and Spanish.
|
|
Simões do Couto, Frederico
PhD student on the Neuroscience Department of the Institute of Molecular Medicine, Lisbon, PORTUGAL.
|
Frederico Simões do Couto took his MD degree in 1997, and specialized in Psychiatry in 2005. His main area of interest has been biological psychiatry. Working as basic and clinical researcher he has published 4 papers in international peer reviewed journal with an impact factor over 2, and has participated in more than 20 clinical trials, phases II to IV, either as co- or principal investigator. He is currently a PhD student on the Neuroscience Department of the Institute of Molecular Medicine, Lisbon.
|
|
Taylor, David
Chief Pharmacist at the Maudsley Hospital and Professor of Psychopharmacology at King's College, London, UNITED KINGDOM
|
David Taylor has also previously been President of the College of Mental Health Pharmacists and Chairman of the UK Psychiatric Pharmacy Group. Professor Taylor has published over 150 research and review papers in psychiatric peer-reviewed journals and received around 2000 citations (H index, 24). His interests include naturalistic outcome studies, pharmacokinetics and pharmacoeconomics. He has also written or edited several books including Schizophrenia in Focus (Pharmaceutical Press), The Use of Drugs in Psychiatry (Gaskell) and Case Studies in Psychopharmacology (Dunitz). Professor Taylor has been the lead author of the Maudsley Prescribing Guidelines since their inception in 1993. The Maudsley Guidelines represent one of the most influential texts in psychiatric prescribing having sold around 150,000 copies.
|
|
Treasaden, Ian
Head of Forensic Neurosciences, Lipid Neuroscience Group, Imperial College, London, and Clinical Director, Three Bridges Medium Secure Unit for Mentally Disordered Offenders, West London Mental Health NHS Trust, UNITED KINGDOM
|
Dr I H Treasaden M.B., B.S., LRCP., MRCS., FRCPsych. LLM. is Head of Forensic Neurosciences, Lipid Neuroscience Group, Imperial College, London, England and, since 1984, he has been Consultant Forensic Psychiatrist at The Three Bridges Medium Secure Unit for mentally disordered offenders, West London Mental Health NHS Trust, where he has also been Clinical Director. He qualified in medicine from the London Hospital Medical College, University of London, in 1975 where he was awarded the James Anderson Prize in Clinical Medicine. He undertook training in forensic psychiatry at the Maudsley & Bethlem Royal Hospitals in London and Broadmoor Special Hospital, Berkshire, England between 1982 and 1984. Author of papers on forensic and general psychiatry, he is also co-author of the books Textbook of Psychiatry, Mental Health Law: A Practical Guide and Emergencies in Psychiatry. His current research interests include lipid and neuro-imaging abnormalities in psychiatric disorders and also violence, including among those with schizophrenia.
|
|
Tsaluchidu Sofia
University of Bologna, ITALY
|
Dr. Sofia Tsaluchidu received her degreee from the University of Bologna IT ( Alma Mater Studiorum Universitá di Bologna) based on her thesis "New Therapeutic Approaches to the Pathology of Parkinson's Disease", involving a detailed study of adenosine A2 antagonists, neuroprotective drugs and neuromelanin inhibitors. She has a particular expertise in fatty acids and oxidative stress and her postgraduate work has included published studies in: comparing oxidative stress in smokers and non-smokers (an in vivo human quantitative study of n-3 lipid peroxidation); the use of artificial neural networks to study fatty acids in neuropsychiatric disorders; and fatty acids and oxidative stress in psychiatric disorders. She is the co-author of the following major paper that is in press in the World Review of Nutrition and Dietetics: The application of serial structural magnetic resonance imaging analysis and proton and 31-phosphorus magnetic resonance spectroscopy to the investigation of cerebral fatty acids in major depressive disorder, Huntington's disease
|
|
Tsapakis, Evangelia
Visiting Research Associate, MRC SGDP Centre, Institute of Psychiatry at King's College, London, UNITED KINGDOM
|
Dr Tsapakis studied Pharmacology at King's College London and Medicine at St. George's Hospital Medical School, University of London. Having earned the First Prize in Psychological Medicine (the Arthur Crisp Prize), she went on to train in Psychiatry at the Maudsley Hospital. She has worked under Ross Baldessarini's mentorship at Harvard Medical School whilst on a Traveling Fellowship awarded by the Royal College of Psychiatrists. In 2007, she gained a Masters in Affective Neuroscience from the University of Maastricht. In 2009, she earned a PhD in Pharmacogenetics (on the role of metabolic enzyme variants in response to treatment with psychotropic agents) and Pharmacogenomics (on differential gene expression induced by antidepressants in juvenile rats) from King's College London, University of London. Dr Tsapakis' awards include a Young Scientist Award at the 11th Biennial Winter Workshop on Schizophrenia (2002), a Research Award at the 5th International Neuropsychiatry Congress (2004), a Young Investigator Award for the 20th International Congress in Schizophrenia Research (2005), and a Poster Prize at the 3rd International Congress on Brain and Behaviour (2007). Dr Tsapakis is a Visiting Research Associate at the Institute of Psychiatry, King's College London and at Harvard Medical School, Boston, MA. Since 2009, she has been the Director of a private Mental Health Unit in Heraklion, Crete
|
|
Tsopelas, Christos
NHS, Consultant in Adult General Psychiatry, Psychiatric Hospital of Attica, GREECE
|
Dr Tsopelas is a graduate of the Ìedical School of Athens. His psychiatric training was completed in Aeginition Hospital , Athens, and Charring Cross Psychiatric training Scheme, London, UK. He has worked in London in various posts, like Community Drug and Alcohol Teams and Crisis Resolution Home Treatment team. The last post was as consultant at South London and Maudsley Trust before he returned to Greece in late 2005 and been part of Greek National Health system and worked for the last 3 years at the Psychiatric Hospital of Attica. He completed his MSc in Psychiatric Research at Institute of Psychiatry, London, UK. He is in the process of finishing his PhD. He has training in Brief Solution Focused Therapy and Interpersonal Psychotherapy. His special interests include Epidemiology, Forensic Psychiatry, patients' rights and community psychiatry. He is secretary of Forensic Psychiatric Section of Hellenic Psychiatric Association and actively involved in organizing and teaching at European co-funded educational programs about de-institutionalization, community psychiatry and forensic psychiatry.
|
|
Van Laerhoven, Kristof
Multimodal Interactive Systems, Department of Computer Science Technische Universität Darmstadt, GERMANY
|
Kristof Van Laerhoven gained his Masters degree from the University of Brussels, Belgium, his PhD from Lancaster University, UK, and is working now as a post-doc at the TU-Darmstadt, Germany. He worked on a large number of national projects in Belgium, the UK, and Germany, as well as numerous EU-funded projects and occasionally acts as expert in EU calls. He is a program committee member of -- among others -- the International Conference on Pervasive Computing (Pervasive) and the International Symposium on Wearable Computers (ISWC) since the last few years. His main interests are in the use of machine learning techniques on sensory data, with practical applications in ubiquitous computing and wearable computing, building systems that are deployable in real-world unpredictable situations, rather than in simulation or controlled lab trials. His core research challenges in these are adopting machine learning techniques in embedded sensors and sensor networks.
|
|
Vieta, Eduar
Professor of Psychiatry and Director of the Bipolar Disorders Program, Hospital Clinic at the University of Barcelona, SPAIN.
|
Eduard Vieta is Professor of Psychiatry and the Director of the Bipolar Disorders Program of the Hospital Clinic at the University of Barcelona, Spain. He also serves as Director of Research at the Clinical Institute of Neuroscience at the same institution. His research focuses on the neurobiology and treatment of bipolar disorder. His programme examines novel pharmacological and psychological treatments, including atypical antipsychotics, antiepileptic drugs, and psychoeducation. Since 2001 his research has been funded by the Stanley Research Medical Institute (Bethesda, USA) and he is the current Director of the Bipolar Research Program at the Spanish Center of Biomedical Research Network on Mental Health (CIBERSAM), funded by the Ministry of Science and Innovation. He has made significant contributions to many of the published bipolar disorder treatment guidelines, and has authored more than 300 original articles, 100 book chapters and 26 complete books, including the recently published 2nd Edition of Bipolar Disorder in Clinical Practice (Current Medicine Group, 2009). He sits on the editorial board of 20 international scientific journals, including The Journal of Clinical Psychiatry, Bipolar Disorders, Psychotherapy Psychosomatics, the Journal of Affective Disorders, and Psychopathology, and he reviews articles for more than 40 others. In 2007, he received the Aristotle award and, ex-aequo with Francesc Colom, the Mogens Schou Award for excellence in bipolar disorder research.
|
|
Vourdas, Apostolos
Consultant in Child and Adolescent Psychiatry, Medical director of Hallowell Center, Athens, GREECE
|
Dr Vourdas graduated from the Ìedical School of Athens, Greece, where he was awarded his PhD in 1996. He was trained in Cambridge and at the Maudsley Hospital in London. He has been an elected Member of the Royal College of Psychiatrists since 2000. He is a trained cognitive and behavioral psychotherapist for children and adolescents. His research interest has been focused on early developmental difficulties in children with psychiatric problems and has been presented in a number of conferences. He worked as a consultant at the Maudsley Hospital before he returned to Greece in 2006. Currently, he is the medical director of Hallowell Center in Athens which specializes in treating people with Attention Deficit Disorder (ADD) and Learning Difficulties. He is also the secretary of forensic psychiatry branch of Hellenic Psychiatric Association and teaches regularly at the Medical School of Athens.
|
|
Yesavage, Jerom
Associate Chief of Staff for Mental Health, VA Palo Alto Heath Care System and Professor of Psychiatry, Stanford University School of Medicine, USA
|
Dr. Yesavage received his MD from Stanford, where he completed his residency in psychiatry. He is Associate chief of staff for Mental Health at the VA Palo Alto Health Care System. He is a member of the American Psychiatric Association, the American Geriatrics Society and the Gerontological Society of America. He has over 400 scientific publications and won the 2009 American Association for Geriatric Psychiatry Distinguished Scientist Award. He directs the Mental Health Research and Education Clinical Center at the VA Palo Alto Health Care System which is devoted to the study of cognitive losses in older veterans suffering from Post-traumatic Stress Disorder (PTSD).
|
|
|
 |
|
|
|
Home
Contact
AWARDS
CONTRIBUTORS